A Study to Evaluate SAGE-217 in Participants With Essential Tremor

计划入组 34 人 · 首次发布于 2016 年 12 月 1 日

Study to Evaluate SAGE-324 in Participants With Essential Tremor

计划入组 146 人 · 首次发布于 2021 年 12 月 29 日

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

计划入组 18 人 · 首次发布于 2020 年 7 月 17 日

Sage

Sage oil

SAGE-817

Sage Therapeutics

United States

Sage Bionetworks

United States

The Sage Colleges

United States

SageMedic's 3D Microtumor Assay Shows Promise for Personalized Cancer Treatment at AACR 2025

Solengepras Enters Phase 3 for Parkinson's, SAGE-718 Discontinued, and Neurogene Pauses NGN-401 High-Dose Trial

Sage Therapeutics' Alzheimer's Drug Dalzanemdor Fails in Mid-Stage Trial